Abstract
Sleep-disordered breathing (SDB) including both obstructive and central sleep apnea affects up to 70% of all patients with cardiovascular disease. There are multiple mechanisms of abnormal physiology in SDB at play that are deleterious to the heart failure (HF) patient, including intermittent hypoxia, sympathetic overdrive, and endothelial dysfunction accompanied by oxidative stress. The mainstay of treatment of SDB in HF patients involves the use of positive airway pressure devices similar to that in non-HF patients. Evaluation and treatment of SDB in patients with HF can improve survival and quality of life and likely decrease arrhythmia.
| Original language | English (US) |
|---|---|
| Title of host publication | Encyclopedia of Cardiovascular Research and Medicine |
| Publisher | Elsevier |
| Pages | 438-441 |
| Number of pages | 4 |
| Volume | 1-4 |
| ISBN (Electronic) | 9780128051542 |
| ISBN (Print) | 9780128096574 |
| DOIs | |
| State | Published - Jan 1 2017 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- General Medicine
Fingerprint
Dive into the research topics of 'Sleep-Disordered Breathing and Heart Failure Interactions and Controversies'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver